Literature DB >> 6306629

Pseudoerythrocytosis in myeloma with associated peripheral neuropathy.

S P Lockhart, T A Phaure.   

Abstract

A number of unusual features have been described in patients who have peripheral neuropathy in association with plasma cell neoplasia. Amongst these features are raised haemoglobins and increased platelet counts. We have measured the red cell mass in one such patient and have shown that the raised haemoglobin was due to a pseudoerythrocytosis. Our patient is also of interest because of his youth being only 19 years old at presentation.

Entities:  

Mesh:

Year:  1983        PMID: 6306629      PMCID: PMC2417494          DOI: 10.1136/pgmj.59.690.266

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


  7 in total

1.  Peripheral neuritis in myelomatosis.

Authors:  R S CROW
Journal:  Br Med J       Date:  1956-10-06

2.  A unique multisystemic syndrome of unknown origin.

Authors:  H Meshkinpour; C G Myung; L S Kramer
Journal:  Arch Intern Med       Date:  1977-12

3.  Thrombocytosis in multiple myeloma.

Authors:  A P Zimelman
Journal:  Ann Intern Med       Date:  1973-06       Impact factor: 25.391

4.  Blood volume in monoclonal gammopathy.

Authors:  R Alexanian
Journal:  Blood       Date:  1977-02       Impact factor: 22.113

5.  Plasma cell neoplasia with peripheral polyneuropathy. A study of five cases and a review of the literature.

Authors:  H Driedger; W Pruzanski
Journal:  Medicine (Baltimore)       Date:  1980-07       Impact factor: 1.889

6.  Plasma cell dyscrasia with polyneuritis and dermato-endocrine alterations. Report of a new case outside Japan.

Authors:  M S Moya-Mir; F Martin-Martin; R Barbadillo; V Cuervas-Mons; T Martin-Jimenez; I Sanchez-Miro; J A Garcia-Merino
Journal:  Postgrad Med J       Date:  1980-06       Impact factor: 2.401

7.  Peripheral neuropathy and plasma cell neoplasias: a report of 10 cases.

Authors:  M C Delauche; J P Clauvel; M Seligmann
Journal:  Br J Haematol       Date:  1981-07       Impact factor: 6.998

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.